Glucagon-like peptide 1 receptor agonists improve prognosis of patients with inflammatory bowel disease

Authors

• J. Jishu, Tulane University, New Orleans, LA
• D. Bruce, Tulane School of Medicine, New Orleans, LA
• Alexandra Laforteza, LSU Health Sciences Center - New OrleansFollow
• F. Shahid, Louisiana State University School of Medicine, Shreveport, LA
• S. Shrestha, Louisiana State University School of Medicine, Shreveport, LA
• M. Hussein, Ochsner Clinic Foundation, New Orleans, LA
• E. Toraih, Suez Canal University, Ismailia, Egypt

Document Type

Conference Proceeding

Publication Date

2-13-2026

Publication Title

The American Journal of the Medical Sciences

Abstract

2026 Southern Regional Meeting, February 26–28, 2026, New Orleans, LA

First Page

S348

Last Page

S349

Volume

371

Issue

Supplement 1

Comments

Abstract #558

Rights

© 2025 Published by Elsevier Inc.

Recommended Citation

Jishu, J.; Bruce, D.; Laforteza, Alexandra; Shahid, F.; Shrestha, S.; Hussein, M.; and Toraih, E., "Glucagon-like peptide 1 receptor agonists improve prognosis of patients with inflammatory bowel disease" (2026). School of Medicine Faculty Publications. 5146.
https://digitalscholar.lsuhsc.edu/som_facpubs/5146
10.1016/j.amjms.2025.12.562